Description of Event or Problem · 0
A MEDWATCH FORM, MW5169611 WAS RECEIVED BY COLLAGEN MATRIX, INC. ON MAY 7, 2025. THE MEDWATCH FORM INDICATES THAT A STRAUMANN® MEMBRANE FLEX WAS USED IN A PROCEDURE IN CONJUNCTION WITH OTHER UNKNOWN PRODUCTS. THE INITIAL REPORTER INDICATED APPROXIMATELY 1 TO 1.5 MONTHS POST-IMPLANTATION THE REPORTER EXPERIENCED SIGNIFICANT FACIAL SWELLING, PREDOMINATELY ON THE LEFT SIDE, THE AREA IN WHICH SHE RECEIVED THE IMPLANT. SUBSEQUENT INVESTIGATION REVEALED THAT THE IMPLANT CONTAINED ALUMINUM AND TITANIUM ALLOY. THE REPORTER LATER LEARNED THAT ALUMINUM WAS SUBSEQUENTLY REMOVED FROM THE IMPLANT COMPOSITION, BUT IT WAS PRESENT AT THE TIME OF HER PROCEDURE. DESPITE EXPLANATION AT AN UNKNOWN DATE IN 2025, THE REPORTER STATES THAT THE FACIAL SWELLING PERSISTS TWO YEARS AFTER INITIAL IMPLANTATION. AFTER REVIEW OF THE EVENT, IT HAS BEEN CONCLUDED THAT MULTIPLE PRODUCTS WERE USED DURING THE PROCEDURE INCLUDING A STRAUMANN® MEMBRANE FLEX. STRAUMANN® MEMBRANE FLEX RESORBABLE COLLAGEN MEMBRANE IS A WHITE, NONFRIABLE, RESORBABLE, SINGLE LAYERED, CONFORMABLE COLLAGEN MEMBRANE MATRIX MANUFACTURED FROM PURIFIED PORCINE PERITONEUM. STRAUMANN® MEMBRANE FLEX IS STERILIZED BY GAMMA IRRADIATION AND IS SUPPLIED STERILE, NON-PYROGENIC, AND FOR SINGLE USE ONLY. STRAUMANN® MEMBRANE FLEX DOES NOT CONTAIN ALUMINUM AND TITANIUM AS DESCRIBED IN THE INITIAL COMPLAINT DESCRIPTION. ACCORDING TO THE INSTRUCTIONS FOR USE, CLINICIANS SHOULD USE CARE IN SCREENING THEIR PATIENTS FOR ANY KNOWN ALLERGIES TO COLLAGEN. HYPERSENSITIVITY REACTIONS HAVE BEEN NOTED WITH THE USE OF OTHER PRODUCTS CONTAINING COLLAGEN; THEREFORE, THE POSSIBILITY EXISTS OF DEVELOPING A LOCAL SENSITIVITY RESPONSE TO STRAUMANN® MEMBRANE FLEX. POSSIBLE COMPLICATIONS THAT CAN OCCUR WITH ANY DENTAL SURGERY INCLUDE INFECTION, SWELLING OF THE INTRAORAL TISSUE, THERMAL SENSITIVITY, GINGIVAL RECESSION, EXCESSIVE GINGIVAL BLEEDING, FLAP SLOUGHING, RESORPTION OR ANKYLOSIS, WITH LOSS OF CRESTAL BONE HEIGHT, PAIN, OR COMPLICATIONS ASSOCIATED WITH THE USE OF ANESTHESIA. MINOR DISCOMFORT MAY OCCUR FOR A FEW DAYS. ACCORDING TO THE MEDWATCH FORM, THE INITIAL REPORTER CHOSE TO REMAIN CONFIDENTIAL, PREVENTING ANY FOLLOW-UP QUESTIONS. NO FURTHER INFORMATION SURROUNDING THE EVENT, PATIENT STATUS, AND PATIENT OUTCOME WILL BE PROVIDED.